#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic thrombocytopenic purpura Human papilloma virus immunisation Acute promyelocytic leukaemia Hypomagnesaemia Ataxia telangiectasia Chronic myelomonocytic leukaemia Leukocyte adhesion deficiency Gastrointestinal neuroendocrine tumour Selective polysaccharide antibody deficiency Deafness bilateral B-cell small lymphocytic lymphoma refractory Liposarcoma Epstein-Barr virus infection Haemolytic uraemic syndrome Peritoneal mesothelioma malignant More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome Soft tissue sarcoma – Trials in Disease Proteus syndrome – Life with Disease Tuberous sclerosis complex – Diagnostics Pulmonary fibrosis Hepatoblastoma – Basic Information Undifferentiated sarcoma – Basic Information Alagille syndrome Hypereosinophilic syndrome – Diagnostics Inclusion body myositis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lib-01 Monohydrate AMO959 Remifentanil Hydrochloride S095035 Cefoxitin Sxr1096 AZD5148 Crofelemer Vesleteplirsen Bdc-1001 Enmetazobactam [14C] DC-806 Silibinin L-Arginine Hydrochloride Dog Epithelium Extract Epoetin Alfa Rtp-026 Sodium Atidarsagene Autotemcel Testosterone Undecanoate Sodium Hydrogen Carbonate More therapies…

    Learn about Your Condition

    Urethral stenosis Thrombolysis HER2 positive breast cancer Thymoma Gender dysphoria Schizophrenia Dysmenorrhoea Hypotransferrinaemia Becker's muscular dystrophy Thromboembolectomy Sexual dysfunction Hereditary optic atrophy Deafness bilateral Hysterectomy Thrombocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • OLVEREMBATINIB
    • Bosutinib
    Belgium France Germany Italy Poland Spain

  • Evaluation of Oxygen Administration Methods During One-Lung Ventilation in Patients Undergoing Lung Resection Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary resection
    Investigated Drugs:
    • Oxygen
    Spain

  • Study on Losartan and Hydrochlorothiazide for Osteogenesis Imperfecta in Patients Aged 16 and Above

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Hydrochlorothiazide
    • Losartan Potassium
    Italy

  • Study on Carvedilol for Preventing Complications in Patients with Early-Stage Cirrhosis and High Blood Pressure in the Liver

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    Investigated Drugs:
    • Carvedilol
    France

  • Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn’s Disease After Inadequate Response to Other Treatments

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Obefazimod
    Belgium Czechia France Germany Hungary Italy +5

  • Study on Reducing Bleeding Risk in Fibroid Surgery Using Misoprostol for Patients Undergoing Myomectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Uterine leiomyoma
    Investigated Drugs:
    • Misoprostol
    • Placebo
    France
Previous Page
1 … 258 259 260 261 262 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!